Lincomycin Hydrochloride is a lincosamide‑class antibiotic supplied as an active pharmaceutical ingredient for antibacterial drug manufacturing. Identified by CAS 7179‑49‑9, it is the hydrochloride salt of lincomycin, formulated to improve stability and aqueous solubility for pharmaceutical use. Its antibacterial activity is primarily directed against Gram‑positive organisms, supporting its role as an API for antibiotic formulations under controlled pharmaceutical production standards.
This product is manufactured under pharmaceutical quality systems, supplied with complete DMF‑support documentation, MSDS, COA, and is available for regulated bulk API supply.
Lincomycin Hydrochloride CAS 7179‑49‑9
- CAS: 7179‑49‑9
- Synonyms: Lincomycin hydrochloride, Lincomycin HCl, Lincomycin API
- Einecs: 212-726-7
- Molecular Formula: C18H34N2O6S
- Grade: Industrial grade 99%
- Package: 200kg iron drum or 50kg plastic drum packaging
Product Description
Lincomycin Hydrochloride
Chemical formula: C18H34N2O6S
CAS:7179‑49‑9
Alias: Gyremycin
Molecular weight: 461.02
Boiling point: 646.8°C at 760 mmHg
Flash point: 345°C
Vapor pressure: 1.85E-19mmHg at 25°CProperties: white crystalline powder; There is a slight or special odor; Bitter taste. This product is easily soluble in water or methanol and slightly soluble in ethanol.
Specification: 25kg/drum
Uses: It is a narrow-spectrum antibiotic with a similar effect to erythromycin, and has a good effect on gram-positive cocci, especially against anaerobic, Staphylococcus aureus and pneumococcus. Its mechanism of action is similar to erythromycin and is a bacteriostatic agent. It mainly inhibits the synthesis of bacterial cell proteins, and is mainly used clinically for various infections caused by sensitive bacteria, such as pneumonia, meningitis, endocarditis, cellulitis, and tonsillitis , erysipelas, boils and urinary system infections, etc.

FAQ - Technical & Supply Chain
-
Q:
Why is Lincomycin supplied as the hydrochloride salt instead of the free base?
A: The hydrochloride salt form provides improved stability and solubility compared with lincomycin free base, which is important for consistent API performance in pharmaceutical formulations. -
Q:
Is Lincomycin Hydrochloride CAS 7179‑49‑9 suitable for direct formulation use?
A: Yes. As an API, it is intended for further pharmaceutical formulation under GMP conditions rather than direct end‑use, and it must meet pharmacopeial specifications before use.
Documents and Product Support
For product review and sourcing evaluation, supporting documents can be coordinated according to the product type, inquiry stage, and order requirements.
- COA for batch-based quality reference
- TDS for key physical and chemical information
- SDS / MSDS for handling, storage, and safety reference
- Packing information for sample, trial, and bulk orders
- Technical communication based on application and specification requirements
Information to Confirm Before Quotation
Clear sourcing information helps reduce specification mismatch and allows a more accurate quotation before sample or bulk order discussion.
- Product name and CAS number
- Application or intended end use
- Required purity, grade, or specification
- Sample quantity, trial order, or bulk demand
- Preferred packing form or net weight
- Destination country or port
- Required documents or compliance expectations
Packaging, Storage, and Handling Notes
Packaging form, storage conditions, shelf life, and shipment arrangements should be confirmed according to the product characteristics, package size, and destination requirements.
Before order confirmation, buyers are advised to review the corresponding product documents and confirm whether any special storage, labeling, or handling requirements apply.
Sample, Bulk Order and Repeat Supply Support
Support can be arranged for sample discussion, bulk supply planning, packaging confirmation, and routine sourcing communication based on the actual product and order requirements.
For repeat-use formulations or long-term procurement plans, buyers may discuss specification consistency, packaging preferences, delivery expectations, and document coordination in advance.




